SC
Steven Cohen (Point72) disclosed increased in KYVERNA THERAPEUTICS INC
Steven Cohen (Point72) filed a 13F change in KYVERNA THERAPEUTICS INC (501976104) on 2026-05-15, covering period end 2026-03-31.
Action
Increased
Capital
$1,621,347 reported value
Institutional 13F Signals1 evidence source
Why it matters
This signal is anchored to the SEC filing date while retaining the underlying 13F period end.